Launched on October, 24
Prepare, manage and submit your IND, NDA, ANDA or BLA submissions, regardless your level of eCTD expertise. With the eCTD 247 package, simple eCTD submissions can be published by yourself. For more complex submissions, you can get help by using our submission services. Compiling an eCTD submission is just the final step. The key is to have all documents ready on time and accessible. eCTD 247 is a cloud platform that helps you securely manage your regulatory content.
With eCTD 247, the eCTD knowhow is embedded into the software itself in a simplified intuitive manner, thus saving you time, money and resources.
The eCTD247 service is offered in three flexible and practical subscription formats: Essential (low number of submissions, price per sequence), Premium (large number of submissions, price per user) and Enterprise (on premise).
Find more about our eCTD247 platform.
Discover our exclusive new cloud-based service: eCTD247
October 26, 2015
About Ennov
Ennov provides a comprehensive software platform to manage the most demanding processes of life sciences organizations in a compliant and efficient way. With over 20 years of experience, Ennov’s cloud-based solutions cover Regulatory Affairs, Pharmacovigilance, Quality, Clinical, and Document Management. Dedicated to innovation and excellence, Ennov’s solutions are used by more than 450 Life Science companies and 500,000 users worldwide, helping them to bring their products to market faster while maintaining compliance with regulatory requirements.
Share :
Facebook
Twitter
LinkedIn
Register for free to access to our library of exclusive content!
- White Papers
- Case Studies
- Product Demos
- Industry Briefs
- and more...
Highlight Post
Recent Posts
Ennov and CognifAI Partner for AI-Driven Pharmacovigilance
October 10, 2024
Ennov to Exhibit at ICTMC 2024
September 24, 2024
Ennov to Exhibit at RAPS Convergence 2024
August 20, 2024
Archives
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- November 2020
- July 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- November 2018
- September 2018
- June 2018
- March 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- June 2016
- October 2015
- June 2015
- April 2015
- February 2015
- December 2014
- November 2014